|
⚲
|
| Keyboard |
| Monte Rosa Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001826457 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001826457] | |
| 10-Q | [0001826457] | |
| 3 | [0001826457] | |
| 4 | [0001826457] | |
| 8-K | [0001826457] | |
| D | [0001826457] | |
| SC 13D | [0001826457] | |
| SC 13G | [0001826457] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Monte Rosa Therapeutics Inc | |
| Townson Sharon | |
| Behbahani Ali | |
| Janku Filip | |
| Manning Anthony M | |
| Champoux Jennifer | |
| Hughes Eric A | |
| Skvarka Jan | |
| Siu Christine | |
| Schiff Andrew N | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-03-04 | Sell | 139 | $17.96 | 2,496 |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Option exercise | 536 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-03-02 | Sell | 536 | $17.50 | 9,380 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-03-02 | Sell | 5,466 | $17.92 | 97,951 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-03-02 | Option exercise | 536 | $13.41 | 7,188 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-02-27 | Option exercise | 25,164 | $13.41 | 337,449 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-02-27 | Sell | 25,164 | $18.10 | 455,468 |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2026-02-27 | Option exercise | 25,164 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-02-23 | Sell | 9,189 | $19.50 | 179,186 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-07 | Sell | 3,707 | $23.24 | 86,151 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-07 | Sell | 309 | $24.57 | 7,592 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-07 | Sell | 1,450 | $23.88 | 34,626 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-05 | Sell | 3,155 | $15.17 | 47,861 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-05 | Sell | 1,039 | $15.17 | 15,762 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-05 | Sell | 10,135 | $15.17 | 153,748 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-05 | Sell | 3,155 | $15.17 | 47,861 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-05 | Sell | 3,155 | $15.17 | 47,861 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-05 | Sell | 2,629 | $15.17 | 39,882 |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 158,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-02 | Grant | 28,000 | ||
| showing 20 of 200 most recent transactions | |||||